(Q45081533)

9 December 2017

title

Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice (English)

1 reference

9 December 2017

1 reference

Guo-Liang Yu

1

1 reference

9 December 2017

Er-Qing Wei

2

1 reference

9 December 2017

Shi-Hong Zhang

3

1 reference

9 December 2017

Hui-Ming Xu

4

1 reference

9 December 2017

Li-Sheng Chu

5

1 reference

9 December 2017

Wei-Ping Zhang

6

1 reference

9 December 2017

Qi Zhang

7

1 reference

9 December 2017

Zhong Chen

8

1 reference

9 December 2017

Ru-Huan Mei

9

1 reference

9 December 2017

Meng-Hui Zhao

10

1 reference

9 December 2017

publication date

27 September 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

73

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

31-40

1 reference

Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils

9 December 2017

cites work

1 reference

Production of leukotrienes in a model of focal cerebral ischaemia in the rat

21 January 2018

1 reference

Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury.

21 January 2018

1 reference

Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans

21 January 2018

1 reference

Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions

21 January 2018

1 reference

Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats.

21 January 2018

1 reference

The effect of nordihydroguaiaretic acid on leukotriene C4 and prostaglandin E2 production following different reperfusion periods in rat brain after forebrain ischemia correlated with morphological changes.

21 January 2018

1 reference

Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.

21 January 2018

1 reference

Effect of the free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), on hypoxia-ischemia-induced brain injury in neonatal rats

21 January 2018

1 reference

Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters

21 January 2018

1 reference

Reversible middle cerebral artery occlusion without craniectomy in rats

21 January 2018

1 reference

Evaluation of a motor deficit after chronic focal cerebral ischemia in rats.

21 January 2018

1 reference

Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.

21 January 2018

1 reference

Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats.

21 January 2018

1 reference

Characterization of the human cysteinyl leukotriene 2 receptor

21 January 2018

1 reference

Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors

21 January 2018

1 reference

Human umbilical vein endothelial cells generate leukotriene C4 via microsomal glutathione S-transferase type 2 and express the CysLT(1) receptor

21 January 2018

1 reference

Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses

21 January 2018

1 reference

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

21 January 2018

1 reference

Protective effect of 3-methyl-1-phenyl-2-pyrazolin-5-one, a free radical scavenger, on acute toxicity of paraquat in mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000081072

1 reference

9 December 2017

1 reference